PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Consensus measurement framework for community pharmacy medication review outcomes

medication reviewcommunity pharmacycore outcome setcore outcome measurement setEQ-5D-5LSTOPP/STARTpolypharmacypotentially inappropriate medicationsdrug-drug interactionsgeriatricsconsensus studyoutcome measurement Geriatrics / Geriatric Pharmacy

Background Information

Harmonizing outcome measures boosts medication review quality for older adults.

Standardizing outcome measurements can enhance the comparability and effectiveness of medication reviews for older adults with multimorbidity and polypharmacy. Experts selected EQ-5D-5L for Health-related Quality of Life (HRQoL) and scales for pain relief, creating criteria for overuse, underuse, and potentially inappropriate medications. The Core Outcome Measurement Set (COMS) enables comparable research and improves the quality of community pharmacist-led medication reviews, although its application may be setting-specific. Standardizing outcome measures advances the efficacy of medication reviews in older patients.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Vogt CJ, Eickhoff C, Foulon V, Hughes C, Kessler J, Paul C, Ryan C, Schulz M, Teichert M, Woltersdorf R, Wurmbach VS, Seidling HM

Citation: Vogt CJ, Eickhoff C, Foulon V, et al. Development of a Core Outcome Measurement Set for studies of community pharmacist-led medication reviews in older patients with multimorbidity and polypharmacy. International journal of clinical pharmacy. 2026;48(6):2467-2478. doi:10.1007/s11096-026-02223-y

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.